News

Nalu's Pioneering Neurostimulation System Shows Remarkable Results

Nalu's Pioneering Neurostimulation System Shows Remarkable Results

Groundbreaking Outcomes from Nalu’s Neurostimulation Study

Recent findings from the Nalu COMFORT randomized control trial signify a major breakthrough in chronic pain management. The one-year data published confirm Nalu's peripheral nerve stimulation (PNS) technology as an effective method for providing lasting pain relief and enhancing overall functionality. This impressive research highlights the enduring capabilities of Nalu's innovative approach.

Lasting Pain Relief Achieved

The results from the trial, involving 61 participants, illustrate a remarkable achievement:

  • 87% of patients reported experiencing a 50% or greater reduction in pain.
  • A notable average reduction in pain levels of 69%.
  • Overall, 95% of patients indicated an improvement in their condition.

Such significant findings support the Nalu Neurostimulation System in establishing itself as the primary solution for PNS. The implications of this data extend to assisting greater insurance coverage for PNS treatments, making this technology accessible to patients who previously faced limitations.

Enhancements in Health and Well-being

Alongside pain reduction, many trial participants reported notable improvements in their general health status after one year:

  • 78% observed a decrease in symptoms of depression.
  • 73% noted reduced levels of disability.
  • 70% experienced improvements in their quality of life.

John Hatheway, MD, who led the investigation, expressed enthusiasm about these findings, stating that this study underscored Nalu’s PNS therapy as delivering robust and substantial improvements across multiple dimensions of patient health. Such long-term benefits have not been previously documented in related areas.

About Nalu Medical

Nalu Medical is an innovative medical technology organization rooted in Carlsbad, California. The company is dedicated to creating minimally invasive solutions aimed at alleviating chronic neuropathic pain. Utilizing advanced technology, the Nalu Neurostimulation System conveys gentle electrical impulses to interfere with pain signals, effectively preventing their transmission to the brain.

Exploring the Nalu Neurostimulation System

The Nalu System features a compact, battery-free, implantable pulse generator that operates wirelessly with an external Therapy Disc. This small but powerful system functions similarly to larger pulse generators while offering unique benefits such as advanced treatment waveforms, extensive programming capabilities, and remarkable upgradability. The expected operational life of the Nalu System extends up to 18 years. Moreover, it has gained multiple awards for its innovative design and was recognized among the top new products globally.

Clinical Applications of Nalu Technology

The Nalu SCS System is designed for managing chronic intractable pain in the trunk and limbs. It may be used either as a standalone solution or in conjunction with other therapies within a multidisciplinary treatment framework. Additionally, the Nalu PNS System is specifically tailored for adults suffering from severe chronic pain related to peripheral nerves. The trial devices employed in the study evaluate their efficacy within a limited time before transitioning to a permanent solution.

Frequently Asked Questions

What is the Nalu Neurostimulation System?

The Nalu Neurostimulation System is an advanced medical device designed to provide pain relief through gentle electrical stimulation targeting nerve pathways.

What were the primary findings of the Nalu COMFORT study?

The one-year results highlighted that a significant majority of patients experienced considerable pain reduction and improvements in overall health status.

How does Nalu’s technology compare to traditional methods?

Nalu’s approach is considered more innovative, offering favorable results and fewer side effects compared to many traditional pain management methods.

Who can benefit from the Nalu Neurostimulation System?

Patients suffering from chronic neuropathic pain, especially those who haven't responded well to conventional treatments, may find this device particularly beneficial.

Is the Nalu system FDA-approved?

Yes, the Nalu Neurostimulation System is FDA-cleared for Spinal Cord Stimulation and Peripheral Nerve Stimulation indications.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Beverly Hills MD's Dermal Cream Wins Key Beauty Award

Updated Category News Views 1

A Surprise Win in the Beauty World Who doesn't love an underdog story, right? Beverly Hills MD has slid into the limelight with their Dermal Repair Complex snagging the award for 'Beauty Product of the Year.' Talk about sending shockwaves through the beauty industry! Now, these guys might not be a household name yet, but you better believe they've got everyone's attention...

Continue Reading
Truist Revolutionizes Banking with 2 Billion Insights

Updated Category News Views 3

A New Frontier in Banking Truist is out here flipping the script in digital banking, pushing a staggering 2 billion AI-driven insights since 2023. Imagine that—two billion insights 'till now, providing the kind of financial street smarts that help folks feel less like they're lost at sea and more like they're the captain of their own financial ship, all thanks to Truist...

Continue Reading
Photronics Faces Legal Heat: Key Investor Steps Now

Updated Category News Views 0

Eyes on Photronics: A Legal Quake Anytime you hear a stock price nosedive like a kamikaze just blew up its own runway, it ought to set off every investor's alarms. And if you’re tied into Photronics (NASDAQ:PLAB), buddy, it's time to catch up on what's driving this train off the rails. With a class period stretching from December 2025 through May 2026, the dish is a...

Continue Reading
Missouri American Water's $34.5M Neosho Acquisition Outline

Updated Category News Views 0

Missouri American Water Expands in Neosho, Missouri Well, buckle up because Missouri American Water just sealed the deal to take over Neosho's water and wastewater systems. This acquisition cost them a cool $34.5 million and is bringing 5,400 water and another 5,400 wastewater customers into the fold. Plus, they're welcoming onboard 25 local workers who've been in the...

Continue Reading
Stronghold's Unfulfilled Promise May Cost Coachella Millions

Updated Category News Views 0

Coachella's Taxpayer Gamble City of Coachella decided to pull the plug on a deal that could've kept wallets fuller around here. Stronghold Power Systems officials say their shot at leading the municipal utility project got snagged by some bureaucratic red tape or maybe something else. Procurement Process: Two-year-long selection. Investment by Stronghold: $8 million of...

Continue Reading
Mitrade EU Enhances Investor Safety with New Insurance

Updated Category News Views 4

Mitrade's New Insurance: A Safety Net? Mitrade EU is amping up its game with some fresh insurance perks that catch the eye. They're slapping on some extra insolvency protection for clients trading under their CySEC license. Now that sounds like a financial shield anyone would want. Basically, they're adding another layer to the basic regulatory protections, and without...

Continue Reading
Finzly Launches AI Security Layer Amid Rising Threats

Updated Category News Views 5

Bank Security in the Age of AI You'd think banks, of all places, were impenetrable fortresses. But these days, they're more like digital targets. With AI-driven attacks becoming as common as morning coffee, Finzly's introducing Assure, an AI-powered security and assurance layer. It's about as timely as ever, given the 89% spike in AI-enabled attacks seen last year. When...

Continue Reading
Connected Retail Security: Rising Risks and Fragmented Roles

Updated Category News Views 0

Cyber Threats in the Connected Retail Landscape The retail world isn't what it used to be. Walk into a store today, and you're greeted not just by products but a web of interconnected systems screaming for attention. Sure, you've got your old-school POS systems humming along, but they're just one brittle cog in a rattling machine of IoT devices, cloud platforms, and...

Continue Reading
Lundbeck's Bexicaserin Insights Rock Epilepsy Congress

Updated Category News Views 5

Breaking Down Bexicaserin's Dual Action Seems like Lundbeck's playing the long game with bexicaserin, and boy, are they shaking things up at the European Epilepsy Congress. This isn't your usual sit-back-and-watch situation. They're putting bexicaserin's dual mode of action under a magnifying glass, aiming to hit both sides of the brain's seesaw by increasing inhibitory...

Continue Reading
Little Sunshine's Opens New School in Peoria, AZ

Updated Category News Views 2

Betting On Early Childhood Education Little Sunshine's Playhouse breaks ground on a fresh hub of learning in Peoria, Arizona, and this is no small playdate. It's the dawn of another preschool institution aiming to mold the early years of countless kiddos. The gears turning behind this development are impressive by themselves, but it's what it means for Peoria's families...

Continue Reading

Top 5 Most Recently Viewed Articles

Mid-Cap Surge Signals Positive Market Trends for 2026

Updated Category News Views 230

Key Market Highlights The global equities market is experiencing a strong surge, showcasing a shift in leadership that extends beyond the traditional mega-cap technology industry. This rotation has been particularly evident with mid-cap stocks reaching record highs, a clear indication of improved market breadth and sector balance. Mid-caps have emerged as a favored choice...

Continue Reading
Ruder Finn Achieves Top Ranking Among PR Firms Once Again

Updated Category News Views 444

Ruder Finn Celebrates #2 Ranking on Observer's PR Power List In an exciting announcement, Ruder Finn, one of the leading independent communications and marketing agencies, has achieved the impressive feat of being ranked #2 on Observer's prestigious PR Power List. This recognition underscores the agency's success in the field and highlights its culturally relevant and...

Continue Reading
Visionary Copper and Gold Mines Secures Funding for Growth

Updated Category News Views 153

Exciting Developments at Visionary Copper and Gold Mines Inc. VANCOUVER, British Columbia — Visionary Copper and Gold Mines Inc. (the "Company" or "Visionary") (TSXV: VCG) (OTCQX: VCGMF) is thrilled to share news about its latest initiative, a non-brokered private placement expected to raise up to $3.0 million. The funds generated will significantly contribute to the...

Continue Reading
W. P. Carey Exceeds Expectations with $1.6 Billion in 2024

Updated Category News Views 240

W. P. Carey Reports Record Investment Volume for 2024 W. P. Carey Inc. (NYSE: WPC), a prominent real estate investment trust (REIT) involved in net leasing, has recently unveiled impressive investment achievements for 2024. The company recorded a total investment volume of about $1.6 billion, driven by a robust focus on high-quality assets. This significant figure...

Continue Reading
PleoPharma Makes Strides in Cannabis Withdrawal Treatment

Updated Category News Views 91

Positive Phase 2b Results for PleoPharma's Lead Drug PleoPharma, Inc., a clinical-stage company dedicated to addressing cannabis-related health challenges, has made impressive strides in its research efforts. The company recently shared the outcomes of its Phase 2b clinical trial for its primary drug candidate, PP-01, which is specifically designed to help alleviate...

Continue Reading